2021 Chambers Global Practice Guide in Life Sciences

The chapter provides the latest legal information on challenging the decisions of regulatory bodies; clinical trials; the marketing and online sales; administrative and criminal liabilities; telemedicine; patents and licensing, and developments related to COVID-19. A PDF version of the chapter is available here.

The Hogan Lovells authors include: Natalia Gulyaeva, Office Managing Partner, head of the Global Regulatory & IPMT practice and Life Sciences & Healthcare Industry group for the Moscow office; Julia Gurieva, a senior associate in the Global Regulatory & IPMT practice; and Natalia Spitsyna, an associate in the Global Regulatory & IPMT practice.

The Hogan Lovells Moscow office team has a distinguished track record in the Russian Life Sciences market, including expansion of the world's leading pharmaceutical and healthcare businesses into Russia. They offer clients strategic advice on transactional, IP, regulatory, commercial, and antitrust issues impacting the Life Sciences industry as well as represent the companies in the domestic and international disputes.